Evidence map›Paper›PMID 27255086›Full record

ArticleEMBO reports2016

RAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs.

Hiroaki Kajiho, Yuko Kajiho, Emanuela Frittoli, Stefano Confalonieri, Giovanni Bertalot, Giuseppe Viale, Pier Paolo Di Fiore, Amanda Oldani, Massimiliano Garre, Galina V Beznoussenko and 5 more

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Function and regulation of Rab GTPases in cancers.Cell biology and toxicology · 2024
    Review
  12. Molecular Research and Treatment of Breast Cancer 2.0.International journal of molecular sciences · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Membrane trafficking alterations in breast cancer progression.Frontiers in cell and developmental biology · 2024
    Review
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Hiroaki KajihoIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Yuko KajihoIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Department of Pediatrics, Graduate School of Medicine The University of Tokyo, Tokyo, Japan.
Emanuela FrittoliIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Stefano ConfalonieriIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Giovanni BertalotMolecular Medicine Program, European Institute of Oncology, Milan, Italy.
Giuseppe VialeDepartment of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy Department of Pathology, European Institute of Oncology, Milan, Italy.
Pier Paolo Di FioreIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
Amanda OldaniIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Massimiliano GarreIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Galina V BeznoussenkoIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Andrea PalamidessiIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Manuela VecchiIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy.
Philippe ChavrierInstitut Curie, PSL Research University, Paris Cedex 05, France Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144 CNRS UMR 144, Paris Cedex 05, France.
Frank PerezInstitut Curie, PSL Research University, Paris Cedex 05, France Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144 CNRS UMR 144, Paris Cedex 05, France.ORCID 0000-0002-9129-9401
Giorgio ScitaIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy Giorgio.Scita@ifom.eu.ORCID 0000-0001-7984-1889
IFOM · ITCentre National de la Recherche Scientifique · FRUniversity of Milan · ITEuropean Institute of Oncology · IT

Funding

European Research Council 268836Worldwide Cancer Research 14-0335
6 · The paper itself

Abstract

The mechanisms of tumor cell dissemination and the contribution of membrane trafficking in this process are poorly understood. Through a functional siRNA screening of human RAB GTPases, we found that RAB2A, a protein essential for ER-to-Golgi transport, is critical in promoting proteolytic activity and 3D invasiveness of breast cancer (BC) cell lines. Remarkably, RAB2A is amplified and elevated in human BC and is a powerful and independent predictor of disease recurrence in BC patients. Mechanistically, RAB2A acts at two independent trafficking steps. Firstly, by interacting with VPS39, a key component of the late endosomal HOPS complex, it controls post-endocytic trafficking of membrane-bound MT1-MMP, an essential metalloprotease for matrix remodeling and invasion. Secondly, it further regulates Golgi transport of E-cadherin, ultimately controlling junctional stability, cell compaction, and tumor invasiveness. Thus, RAB2A is a novel trafficking determinant essential for regulation of a mesenchymal invasive program of BC dissemination.

Indexed as

Biomarkers, TumorBreast NeoplasmsCadherinsCell Line, TumorEndosomesExocytosisExtracellular MatrixFemaleGene ExpressionGene Expression ProfilingGene SilencingGolgi ApparatusHomeodomain ProteinsHumansMatrix Metalloproteinase 14Neoplasm InvasivenessBiomarkers, TumorCadherinsHomeodomain ProteinsHOPX protein, humanMatrix Metalloproteinase 14MMP14 protein, humanrab GTP-Binding ProteinsTumor Suppressor Proteinscancer migration and invasionmembrane traffickingRAB2ARAB GTPases

Identifiers

PMID27255086
PMCPMC4931572
OpenAlexW2412343245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.